Cydan Development
Cydan Development is the first orphan drug accelerator dedicated to advancing therapies that improve the lives of patients with rare genetic diseases.
Cydan identifies and de-risks drug candidates and forms stand-alone companies and strategic partnerships to support the successful development of the most promising drug candidates. Vtesse, Imara, and Tiburio are among the company spinouts from Cydan.
